The follow-up brought little surprise, with investigators pleased the risk of death/disabling stroke remained on par with ...

CHICAGO -- Transcatheter aortic valve replacement (TAVR) continued to hold its own against surgery for younger patients at ...

The following is a summary of "Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients ...

Findings from the first 500 patients treated with the Trilogy system met noninferiority for both safety and efficacy.

Medtronic says its Evolut TAVR shows strong valve performance and durable outcomes at 5 years in low-risk aortic stenosis ...

Among patients with severe aortic stenosis at low surgical risk, transcatheter aortic valve replacement and surgery conferred ...

As heart failure patients, the TAVI population studied already is recommended to be treated with an SGLT2 inhibitor, noted ...

A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve ...

Although TAVI compares favorably to conservative ... score and the logistic EuroSCORE were developed mostly in low to intermediate risk patients, and there were very little high-risk patients ...

[5] present the results of a TAVI population stratified by left ventricular ... A normal LVEF with a small AVAi, indicates low flow, but no SVI are reported. The group with low flow/low gradients ...